Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments - Summary of Changes in Level One and Level Three Financial Assets (Detail)

v3.24.2.u1
Financial Instruments - Summary of Changes in Level One and Level Three Financial Assets (Detail) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Loss on equity method investments $ (122) $ 0
4 Front Venture Corp [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Beginning balance 56  
Revaluations (9)  
Ending balance 47  
Other Long-term Investments [Member] | The Pharm Stand, LLC [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Beginning balance 0  
Additions 125  
Ending balance 125  
Other Long-term Investments [Member] | Island Thyme LLC [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Beginning balance 679  
Additions 195  
Loss on equity method investments (122)  
Ending balance $ 752